Rubric Capital Management LP Arcutis Biotherapeutics, Inc. Transaction History
Rubric Capital Management LP
- $3.59 Billion
- Q3 2024
A detailed history of Rubric Capital Management LP transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Rubric Capital Management LP holds 10,966,672 shares of ARQT stock, worth $164 Million. This represents 2.84% of its overall portfolio holdings.
Number of Shares
10,966,672
Previous 9,816,672
11.71%
Holding current value
$164 Million
Previous $91.3 Million
11.71%
% of portfolio
2.84%
Previous 2.7%
Shares
10 transactions
Others Institutions Holding ARQT
# of Institutions
197Shares Held
129MCall Options Held
738KPut Options Held
82K-
Jennison Associates LLC11.7MShares$175 Million0.07% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.7MShares$161 Million3.92% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$132 Million4.4% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$129 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.96MShares$104 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $902M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...